Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

0.4184

+0.0312 (8.06%)

At close: Nov 13, 2026, 4:00 PM EST

0.4252

+0.0068 (1.63%)

After-hours: Nov 13, 2026, 7:47 PM EST

Ensysce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29.67	4.31	3.5	1.12	3.15	12.26
Cash & Short-Term Investments	29.67	4.31	3.5	1.12	3.15	12.26
Cash Growth	1673.28%	23.08%	211.68%	-64.30%	-74.33%	6215.06%
Receivables	0.04	0.42	0.12	0.1	0.28	0.44
Prepaid Expenses	1.08	0.41	0.36	0.51	0.55	0.81
Other Current Assets	-	2.11	1.36	0.55	1.33	2.15
Total Current Assets	30.8	7.24	5.34	2.29	5.3	15.66
Property, Plant & Equipment	0.16	0.12	-	-	-	-
Other Long-Term Assets	-	0.09	0.25	0.42	0.59	0.75
Total Assets	30.95	7.45	5.6	2.71	5.89	16.42

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.03	3.27	1.36	1.94	2.94	0.3
Accrued Expenses	1.65	0.99	0.55	0.54	2.23	3.41
Short-Term Debt	0.15	0.31	0.3	0.85	4.27	-
Current Portion of Long-Term Debt	-	-	-	-	-	12.75
Current Portion of Leases	-	-	-	-	0.03	0.02
Total Current Liabilities	3.84	4.57	2.21	3.33	9.46	16.48
Long-Term Debt	-	-	-	-	0.14	4.44
Other Long-Term Liabilities	-	-	0.01	0.03	0.31	3.65
Total Liabilities	3.84	4.57	2.22	3.36	9.91	24.58

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	255.64	142.93	133.25	121.23	107.22	77.97
Retained Earnings	-227.96	-139.72	-129.54	-121.56	-110.93	-85.85
Total Common Equity	27.44	3.21	3.71	-0.32	-3.71	-7.88
Minority Interest	-0.33	-0.33	-0.33	-0.33	-0.32	-0.28
Shareholders' Equity	27.11	2.88	3.38	-0.65	-4.03	-8.16
Total Liabilities & Equity	30.95	7.45	5.6	2.71	5.89	16.42

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.15	0.31	0.3	0.85	4.43	17.21
Net Cash (Debt)	29.52	4	3.2	0.27	-1.29	-4.95
Net Cash Growth	2196.04%	25.10%	1090.16%	-	-	-
Net Cash Per Share	2.82	1.57	4.59	1.78	-107.24	-
Filing Date Shares Outstanding	19.46	9.28	1.41	0.49	0.09	0.02
Total Common Shares Outstanding	19.46	4.57	1.36	0.21	0.04	-
Working Capital	26.96	2.67	3.14	-1.04	-4.17	-0.82
Book Value Per Share	1.41	0.70	2.74	-1.54	-104.24	-
Tangible Book Value	27.44	3.21	3.71	-0.32	-3.71	-7.88
Tangible Book Value Per Share	1.41	0.70	2.74	-1.54	-104.24	-

SEC Filings: 10-K · 10-Q